We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioscience Vct | LSE:BVP | London | Ordinary Share | GB0031256109 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Feb 2024 to May 2024
Seneca Growth Capital VCT Plc (the "Company")
19 February 2024
Director Declaration
In accordance with LR 9.6.14(2), the Company announces that Ian Dighe, a Non-Executive Director of Seneca Growth Capital VCT Plc was appointed as a non-executive director of Pennant International Group plc (AIM:PEN) with effect from 7 February 2024.
For further information, please contact:
ISCA Administration Services Limited (the Company Secretary) on
01392 487056; or SenecaVCT@iscaadmin.co.uk
1 Year Bioscience Vct Chart |
1 Month Bioscience Vct Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
